• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

劳动力成本上升能否促进私营部门研发投资?:来自中国私营企业调查的证据。

Can rising labor costs boost private sector R&D investment? : Evidence from a survey of Chinese private firms.

机构信息

School of Economics, Harbin University of Commerce, Harbin, Heilongjiang, China.

School of Economics, Wuhan University, Wuhan, China.

出版信息

PLoS One. 2022 Aug 4;17(8):e0268287. doi: 10.1371/journal.pone.0268287. eCollection 2022.

DOI:10.1371/journal.pone.0268287
PMID:35925924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9351998/
Abstract

This paper constructs a double difference model (DID) based on the China Private Enterprise Survey (CPES) data over the period 1995-2019, combined with the 2005 national census data and considering the policy shock of the implementation of the Chinese government's Minimum Wage Regulation in March 2004, to investigate whether rising labor costs promote private firms' innovation investment. Robustness tests are conducted using placebo tests and event study methods. The study finds that (1) rising labor costs significantly increase private firms' R&D investment and that this effect has significant lag and cumulative effects; (2) private industrial firms (especially above-scale private industrial firms) are more affected by rising labor costs than other private firms and have more incentives to increase innovation investment; and (3) innovation investment of below-scale private industrial firms is not significantly affected by rising labor costs.

摘要

本文基于中国私营企业调查(CPES)1995-2019 年的数据构建了双重差分模型(DID),结合 2005 年全国普查数据,并考虑到 2004 年 3 月中国政府实施最低工资规定的政策冲击,考察了劳动力成本上升是否促进了私营企业的创新投资。采用安慰剂检验和事件研究方法进行了稳健性检验。研究结果表明:(1)劳动力成本上升显著促进了私营企业的研发投资,且这种效应具有显著的滞后和累积效应;(2)私营工业企业(尤其是规模以上私营工业企业)受劳动力成本上升的影响大于其他私营企业,并有更大的激励增加创新投资;(3)劳动力成本上升对规模以下私营工业企业的创新投资没有显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0fa/9351998/a50d31e04108/pone.0268287.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0fa/9351998/d8443d6620c8/pone.0268287.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0fa/9351998/a50d31e04108/pone.0268287.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0fa/9351998/d8443d6620c8/pone.0268287.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0fa/9351998/a50d31e04108/pone.0268287.g002.jpg

相似文献

1
Can rising labor costs boost private sector R&D investment? : Evidence from a survey of Chinese private firms.劳动力成本上升能否促进私营部门研发投资?:来自中国私营企业调查的证据。
PLoS One. 2022 Aug 4;17(8):e0268287. doi: 10.1371/journal.pone.0268287. eCollection 2022.
2
The impact of economic policy uncertainty on firms' investment in innovation: Evidence from Chinese listed firms.经济政策不确定性对企业创新投资的影响:来自中国上市公司的证据。
PLoS One. 2022 Nov 15;17(11):e0272983. doi: 10.1371/journal.pone.0272983. eCollection 2022.
3
The Impact of the Consistency Evaluation Policy of Generic Drugs on R&D Investment Intensity of Pharmaceutical Companies-An Empirical Study Based on the Difference-in-Differences Model.仿制药一致性评价政策对制药企业研发投入强度的影响——基于双重差分模型的实证研究。
Front Public Health. 2022 Jun 9;10:902025. doi: 10.3389/fpubh.2022.902025. eCollection 2022.
4
Will the Volume-Based Procurement Policy Promote Pharmaceutical Firms' R&D Investment in China? An Event Study Approach.基于量的采购政策会促进中国制药企业的研发投资吗?一项事件研究方法。
Int J Environ Res Public Health. 2021 Nov 16;18(22):12037. doi: 10.3390/ijerph182212037.
5
Environmental regulation and green innovation of polluting firms in China.中国的环境规制与污染企业的绿色创新。
PLoS One. 2023 Mar 9;18(3):e0281303. doi: 10.1371/journal.pone.0281303. eCollection 2023.
6
Public funding and private investment for R&D: a survey in China's pharmaceutical industry.研发的公共资金和私人投资:中国制药业的调查。
Health Res Policy Syst. 2014 Jun 13;12:27. doi: 10.1186/1478-4505-12-27.
7
Does digital finance improve the green investment of Chinese listed heavily polluting companies? The perspective of corporate financialization.数字金融是否会提高中国重污染上市公司的绿色投资?基于企业金融化视角。
Environ Sci Pollut Res Int. 2022 Oct;29(47):71047-71063. doi: 10.1007/s11356-022-20803-z. Epub 2022 May 20.
8
Will emission trading promote enterprise diversification? Evidence from China.排放交易是否会促进企业多元化?来自中国的证据。
Environ Sci Pollut Res Int. 2023 Jul;30(32):79194-79214. doi: 10.1007/s11356-023-28115-6. Epub 2023 Jun 7.
9
Family Exit and Firms' Investment Efficiency Based on Dynamic Changes: Evidence from Chinese Family Firms.基于动态变化的家族退出与企业投资效率——来自中国家族企业的证据。
Comput Intell Neurosci. 2022 Jul 31;2022:7572891. doi: 10.1155/2022/7572891. eCollection 2022.
10
How Labor Costs Affect Innovation Output in Pharmaceutical Companies: Evidence from China.劳动力成本如何影响制药公司的创新产出:来自中国的证据。
Inquiry. 2024 Jan-Dec;61:469580241246965. doi: 10.1177/00469580241246965.

引用本文的文献

1
Navigating technological innovation and rising costs: Assessing economic performance in Chinese manufacturing.应对技术创新与成本上升:评估中国制造业的经济表现。
PLoS One. 2025 Jan 3;20(1):e0316556. doi: 10.1371/journal.pone.0316556. eCollection 2025.

本文引用的文献

1
Changing healthcare capital-to-labor ratios: evidence and implications for bending the cost curve in Canada and beyond.不断变化的医疗保健资本与劳动力比率:加拿大及其他地区控制成本曲线的证据与启示
Int J Health Care Finance Econ. 2014 Dec;14(4):339-53. doi: 10.1007/s10754-014-9154-9. Epub 2014 Aug 17.